Importantly, while vaccination with Hsf2 p.K72N68-76 peptide suppressed tumour growth, ACT shows significant anti-tumour effect only with Hsf2 p.K72N68-76 overexpressed by B16F10 cells. The gene discussed is HSF2; the disease is neoplasm.